Table 1.
Physiological properties of SLC39A/ Zrt- and Irt-like protein (ZIP) transporters.
Genes/Proteins | Expression | Subcellular Location | Physiological Functions | Genetic Mutation Study in Mice | References |
---|---|---|---|---|---|
Slc39a1/ZIP1 | Ubiquitous | Plasma membrane | Abnormal embryonic development | Knockout (KO) | [12] |
Slc39a2/ZIP2 | Liver, ovary, skin, dendritic cell | Plasma membrane | Abnormal embryonic development | KO | [15] |
Slc39a3/ZIP3 | Widely distributed | Plasma membrane | Abnormal embryonic and T-cell development | KO | [12] |
Slc39a4/ZIP4 | Small intestine, epidermis | Plasma membrane | Embryonic lethality | KO | [16,17] |
Slc39a5/ZIP5 | Small intestine, kidney, pancreas | Plasma membrane | Intestinal Zn excretion; pancreatic Zn accumulation | KO | [18] |
Slc39a6/ZIP6 | Widely distributed | Plasma membrane | Abnormal gonad formation and E-cadherin expression | - | [19,20] |
Glial cell migration in Drosophila | |||||
Slc39a7/ZIP7 | Widely distributed, colon, skin | Endoplasmic reticulum (ER) and Golgi apparatus | Impaired melanin synthesis, fibroblast growth factor receptor (FGFR) and Notch signaling in Drosophila | KO | [21,22,23] |
Colon epithelial cell differentiation and proliferation in mouse | |||||
Skin dermis development | |||||
Slc39a8/ZIP8 | Widely distributed | Plasma membrane, lysosome | Cdm mouse: Resistance to cadmium-induced testicular damage, embryonic lethality | KO | [24,25] |
Slc39a9/ZIP9 | Widely distributed | Golgi apparatus | Expressed in breast and prostate cancer cell lines | - | [26,27] |
Apoptosis regulation | |||||
Slc39a10/ZIP10 | Widely distributed, renal cell, carcinoma B cell | Plasma membrane | B cell development and function. | KO | [28,29,30] |
Epidermal development | |||||
Breast cancer progression | |||||
Slc39a12/ZIP12 | Brain, pulmonary vascular smooth muscle | Plasma membrane | Neuronal differentiation | KO (Rat) | [31] |
Attenuation of pulmonary hypertension in a hypoxic atmosphere | |||||
Slc39a13/ZIP13 | Hard and connective tissues | Golgi apparatus, vesicles | Growth retardation, abnormal hard and connective tissue development, and adipocyte browning | KO | [32,33] |
Growth retardation and impaired G protein-coupled receptor (GPCR) signaling | |||||
Slc39a14/ZIP14 | Widely distributed, liver, bone, and cartilage | Plasma membrane, endosome | Growth retardation, abnormal chondrocyte differentiation | KO | [34,35,36,37,38] |
Adipokineuction | |||||
Impaired the phosphodiesterase (PDE) activity through GPCR-mediated cAMP-CREB signaling | |||||
Hypertrophic adiposity | |||||
Endotoxemia | |||||
Glucose metabolism | |||||
Impaired ER stress |